Longer Anesthesia Duration Tied to Surgical Complications
|
By HospiMedica International staff writers Posted on 16 Oct 2017 |

Image: A new study suggests anesthesia time should be kept to the minimum to avoid surgical complications (Photo courtesy of Alamy).
A new study suggests that extended anesthesia is associated with significantly increased rates of surgical complications, especially due to postoperative transfusion requirements.
Researchers at Rutgers New Jersey Medical School (NJMS; Newark, USA) conducted a study involving 630 patients who underwent head and neck microvascular reconstruction between 2005 and 2014 to examine the association of anesthesia duration with surgical complications. The patients were stratified into five quintiles based on mean anesthesia duration; group 1 - 358.1 minutes; group 2 - 563.2 minutes; group 3 - 648.9 minutes; group 4 - 736.5 minutes; and group 5 - 922.1 minutes. The main outcomes included rates of postoperative medical and surgical complications and mortality.
The results showed that increasing anesthesia duration was associated with higher 30-day complication rates, 30-day postoperative surgical complications, increased rates of postoperative transfusion, and more wound disruptions. Anesthesia duration was not associated with specific medical complications, overall medical complication rate, or mortality. When accounting for demographics and significant preoperative factors, including free flap type, increased anesthesia duration remained significantly associated with overall complications, surgical complications, and postoperative transfusion. The study was published on October 5, 2017, in JAMA Facial Plastic Surgery.
“These results highlight the need for an awareness of the perioperative and nonsurgical factors that may extend anesthesia time and tactics that promote intraoperative efficiency. One such strategy involves selection of a donor site amenable to concurrent harvesting and implementation of a 2-team approach,” concluded lead author Jacob Brady, MD, and colleagues. “The number of microvascular anastomoses and defect closure that will be required should also be considered in donor site selection. Ultimately, meticulous preoperative planning and preparation should allow surgeons to reduce operating room time, regardless of other nonsurgical factors out of their control.”
General anesthesia is a state produced when a patient receives intravenous and inhaled agents to allow adequate surgical access to the operative site. It is intended to promote amnesia, analgesia, muscle paralysis, and sedation in a controlled, reversible, state of unconsciousness that enables a patient to tolerate surgical procedures that would otherwise inflict unbearable pain, potentiate extreme physiologic exacerbations, and result in unpleasant memories.
Related Links:
Rutgers New Jersey Medical School
Researchers at Rutgers New Jersey Medical School (NJMS; Newark, USA) conducted a study involving 630 patients who underwent head and neck microvascular reconstruction between 2005 and 2014 to examine the association of anesthesia duration with surgical complications. The patients were stratified into five quintiles based on mean anesthesia duration; group 1 - 358.1 minutes; group 2 - 563.2 minutes; group 3 - 648.9 minutes; group 4 - 736.5 minutes; and group 5 - 922.1 minutes. The main outcomes included rates of postoperative medical and surgical complications and mortality.
The results showed that increasing anesthesia duration was associated with higher 30-day complication rates, 30-day postoperative surgical complications, increased rates of postoperative transfusion, and more wound disruptions. Anesthesia duration was not associated with specific medical complications, overall medical complication rate, or mortality. When accounting for demographics and significant preoperative factors, including free flap type, increased anesthesia duration remained significantly associated with overall complications, surgical complications, and postoperative transfusion. The study was published on October 5, 2017, in JAMA Facial Plastic Surgery.
“These results highlight the need for an awareness of the perioperative and nonsurgical factors that may extend anesthesia time and tactics that promote intraoperative efficiency. One such strategy involves selection of a donor site amenable to concurrent harvesting and implementation of a 2-team approach,” concluded lead author Jacob Brady, MD, and colleagues. “The number of microvascular anastomoses and defect closure that will be required should also be considered in donor site selection. Ultimately, meticulous preoperative planning and preparation should allow surgeons to reduce operating room time, regardless of other nonsurgical factors out of their control.”
General anesthesia is a state produced when a patient receives intravenous and inhaled agents to allow adequate surgical access to the operative site. It is intended to promote amnesia, analgesia, muscle paralysis, and sedation in a controlled, reversible, state of unconsciousness that enables a patient to tolerate surgical procedures that would otherwise inflict unbearable pain, potentiate extreme physiologic exacerbations, and result in unpleasant memories.
Related Links:
Rutgers New Jersey Medical School
Latest Critical Care News
- AI Stethoscope Spots Heart Valve Disease Earlier Than GPs
- Bioadhesive Patch Eliminates Cancer Cells That Remain After Brain Tumor Surgery
- Wearable Patch Provides Up-To-The-Minute Readouts of Medication Levels in Body
- New Spray-Mist Device Delivers Antibiotics Directly into Infected Tissue
- Living Implant Could End Daily Insulin Injections
- Intelligent Camera System Continuously Monitors Premature Babies in NICU
- Intranasal Spray to Prevent Illnesses from Respiratory Viruses
- Gut Bacteria from Amphibians and Reptiles Show Complete Tumor Elimination
- High-Dose Inhaled Nitric Oxide Emerges as Promising Antimicrobial Therapy
- AI Risk Prediction Tool Improves Treatment of Cancer Patients after Heart Attack
- Glowing Bacterial Sensors Could Improve Detection of Gut Illness
- Innovative ‘Poop Pills’ Dramatically Improve Cancer Treatment

- New Nanomaterial Kills Cancer Cells While Sparring Healthy Tissues
- AI Model Accurately Predicts Neurological Recovery After Cardiac Arrest
- Battery-Free Nano-Sensors Pave Way for Next-Generation Wearables
- Imaging Technology Detects Early Signs of Cardiovascular Risk Through Skin
Channels
Artificial Intelligence
view channelCritical Care
view channel
AI Stethoscope Spots Heart Valve Disease Earlier Than GPs
Valvular heart disease affects more than half of people over 65, yet it often goes undiagnosed until symptoms become severe. In advanced stages, untreated cases can carry a mortality risk of up to 80%... Read more
Bioadhesive Patch Eliminates Cancer Cells That Remain After Brain Tumor Surgery
Glioblastoma is the most common and aggressive form of brain tumor, characterized by rapid growth, high invasiveness, and an extremely poor prognosis. Even with surgery followed by radiotherapy and chemotherapy,... Read morePatient Care
view channel
Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more
VR Training Tool Combats Contamination of Portable Medical Equipment
Healthcare-associated infections (HAIs) impact one in every 31 patients, cause nearly 100,000 deaths each year, and cost USD 28.4 billion in direct medical expenses. Notably, up to 75% of these infections... Read more
Portable Biosensor Platform to Reduce Hospital-Acquired Infections
Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read moreFirst-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds
Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read moreHealth IT
view channel
EMR-Based Tool Predicts Graft Failure After Kidney Transplant
Kidney transplantation offers patients with end-stage kidney disease longer survival and better quality of life than dialysis, yet graft failure remains a major challenge. Although a successful transplant... Read more
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read moreBusiness
view channel
Medtronic to Acquire Coronary Artery Medtech Company CathWorks
Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Medtronic and Mindray Expand Strategic Partnership to Ambulatory Surgery Centers in the U.S.
Mindray North America and Medtronic have expanded their strategic partnership to bring integrated patient monitoring solutions to ambulatory surgery centers across the United States. The collaboration... Read more
FDA Clearance Expands Robotic Options for Minimally Invasive Heart Surgery
Cardiovascular disease remains the world’s leading cause of death, with nearly 18 million fatalities each year, and more than two million patients undergo open-heart surgery annually, most involving sternotomy.... Read more







